The Oncology Institute, Inc. (TOIIW)
- Previous Close
0.0468 - Open
0.0464 - Bid --
- Ask --
- Day's Range
0.0464 - 0.0603 - 52 Week Range
0.0464 - 0.0603 - Volume
4,567 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
-- - EPS (TTM)
-602.0870 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
theoncologyinstitute.comRecent News: TOIIW
View MoreCompare To: TOIIW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TOIIW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-16.44%
Return on Assets (ttm)
-19.67%
Return on Equity (ttm)
-213.36%
Revenue (ttm)
393.41M
Net Income Avi to Common (ttm)
-53.01M
Diluted EPS (ttm)
-602.0870
Balance Sheet and Cash Flow
Total Cash (mrq)
49.67M
Total Debt/Equity (mrq)
3,434.19%
Levered Free Cash Flow (ttm)
-7.46M